Q&A: Suzanne Topalian on Immune Therapies

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nd2013-016
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Q&A: Lisa Coussens on Immune Reprogramming

Cancer Discovery
Oncology
2012English

Genomics of Immune Diseases and New Therapies

Annual Review of Immunology
AllergyImmunology
2016English

The Effects of Mind-Body Therapies on the Immune System: Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Suzanne Eaton (1959–2019)

Cell
BiochemistryGeneticsMolecular Biology
2019English

Putting a Band-Aid on a Broken Leg: Antiseizure Medications Are Inferior to Immune Therapies in Autoimmune Epilepsy

Epilepsy Currents
Neurology
2019English

Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

Gastroenterology
HepatologyGastroenterology
2016English

Advances in Immune-Modulating Therapies to Treat Atherosclerotic Cardiovascular Diseases

Therapeutic Advances in Vaccines
2013English

What the Oncologist Needs From the Pathologist for Immune Therapies

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy